AR013478A1 - Metodo para aumentar el volumen oseo. - Google Patents

Metodo para aumentar el volumen oseo.

Info

Publication number
AR013478A1
AR013478A1 ARP980104480A ARP980104480A AR013478A1 AR 013478 A1 AR013478 A1 AR 013478A1 AR P980104480 A ARP980104480 A AR P980104480A AR P980104480 A ARP980104480 A AR P980104480A AR 013478 A1 AR013478 A1 AR 013478A1
Authority
AR
Argentina
Prior art keywords
bone volume
increase
prostanoid
agonist
pathways
Prior art date
Application number
ARP980104480A
Other languages
English (en)
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of AR013478A1 publication Critical patent/AR013478A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Métodos novedosos para incrementar el volumen oseo que comprenden activar las vías de cinasa C proteína osteoblástica/calcio intracelular de un sujeto.Además, la invencion se relaciona con un método para tratar y prevenir los trastornos oseosen los cuales la activacion se produce por la admionistracionde un agonista de prostanoide F.
ARP980104480A 1997-09-09 1998-09-08 Metodo para aumentar el volumen oseo. AR013478A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5821897P 1997-09-09 1997-09-09

Publications (1)

Publication Number Publication Date
AR013478A1 true AR013478A1 (es) 2000-12-27

Family

ID=22015432

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980104480A AR013478A1 (es) 1997-09-09 1998-09-08 Metodo para aumentar el volumen oseo.

Country Status (17)

Country Link
EP (1) EP1035853A1 (es)
JP (1) JP2001515863A (es)
CN (1) CN1269720A (es)
AR (1) AR013478A1 (es)
AU (1) AU9130298A (es)
BR (1) BR9811775A (es)
CA (1) CA2303799A1 (es)
CO (1) CO5070621A1 (es)
HU (1) HUP0003584A3 (es)
ID (1) ID24759A (es)
IL (1) IL134759A0 (es)
NO (1) NO20001172L (es)
PE (1) PE118899A1 (es)
PL (1) PL339297A1 (es)
SK (1) SK3402000A3 (es)
WO (1) WO1999012550A1 (es)
ZA (1) ZA988229B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1159266B1 (en) * 1999-03-05 2004-11-03 Duke University C-16 unsaturated fp-selective prostaglandins analogs
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993015767A1 (en) * 1992-02-05 1993-08-19 Merck & Co., Inc. Implant therapy for bone growth stimulation
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis

Also Published As

Publication number Publication date
NO20001172D0 (no) 2000-03-07
NO20001172L (no) 2000-05-08
PL339297A1 (en) 2000-12-04
JP2001515863A (ja) 2001-09-25
AU9130298A (en) 1999-03-29
HUP0003584A3 (en) 2002-12-28
ZA988229B (en) 1999-03-09
WO1999012550A1 (en) 1999-03-18
PE118899A1 (es) 2000-02-03
ID24759A (id) 2000-08-03
EP1035853A1 (en) 2000-09-20
CA2303799A1 (en) 1999-03-18
BR9811775A (pt) 2000-08-29
SK3402000A3 (en) 2000-12-11
HUP0003584A2 (hu) 2001-02-28
CO5070621A1 (es) 2001-08-28
CN1269720A (zh) 2000-10-11
IL134759A0 (en) 2001-04-30

Similar Documents

Publication Publication Date Title
AR013479A1 (es) Metodo para aumentar el volumen oseo utilizando agonistas de prostanoide f selectivos no naturales.
AR005987A1 (es) Terapia combinada para la osteoporosis
PA8484301A1 (es) Formulaciones farmaceuticas de liberacion controlada
GT199800158AA (es) Agonistas de prostaglandinas y su uso para tratar trastornos oseos
ES2127409T3 (es) Metodo para la modulacion de la respuesta sexual en el hombre.
BR0105457A (pt) Combinações terapêuticas para estimulação do crescimento ósseo
PT777483E (pt) Metodos e meio para administrar farmacos
ES2136624T3 (es) Implante biocompatible para regular la ovulacion en yeguas.
ES2164842T3 (es) Procedimiento para la preparacion de composiciones de microcapsulas.
CY1106160T1 (el) Mεταβολιτες βουπροπιονης και μεθοδοι συνθεσης και χρησεις τους
PA8452701A1 (es) Agonistas de prostaglandinas
BR0113184A (pt) Implante artificial e processo para produzir o mesmo
BR0107942A (pt) Polìmeros de proteìna de liberação lenta
ES2172670T3 (es) Pirrolpirimidinas y procedimientos para su preparacion.
CR7059A (es) USO DE AGONISTAS INVERSOS DE GABAa EN COMBINACION CON AGONISTAS PARCIALES DEL RECEPTOR DE NICOTINA, ESTROGENOS, MODULADORES SELECTIVOS DE ESTROGENOS O VITAMINA E PARA EL TRAMIENTO DE TRASTORNOS COGNITIVOS
AR025883A1 (es) Utilizacion de antagonistas de los receptores de los cannabinoides centrales para la preparacion de medicamentos
DK0998287T3 (da) Anvendelse af levobupivacain
ES2168766T3 (es) Preparacion farmaceutica que incluye el propeptido vwf.
ECSP003707A (es) Diazepanes
BR0011174A (pt) Composições, compostos, compostos isolados e métodos para controlar pestes
BR0209199A (pt) Controle de campactabilidade através de cristalização
AR013478A1 (es) Metodo para aumentar el volumen oseo.
UY26265A1 (es) Compuestos calciolíticos
DK0435177T3 (da) 4-Benzyl-5-phenyl-2,4-dihydro-3H-1,2,4-triazol-3-oner samt deres anvendelse som antikonvulsive midler
ES2192874T3 (es) Proteina c para el tratamiento de la enfermedad de la celula con anemia hepatica y talasemia.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal